Jan 28 (Reuters) - Eikon ‍Therapeutics, headed ‌by ​Merck veteran Roger Perlmutter, is ‌targeting a valuation of up to $908.2 ...

These are the formulas that actually work, as tested by a beauty writer ...

DEAR DR. ROACH: I am an 80-year-old female on Eliquis who has many bruises on her legs that do not go away. Is there a remedy ...

A new study warns that a widely used eye ointment can damage a popular glaucoma implant. Researchers found that oil-based ...

Teresa Sanchez was in Mexico for a medical procedure nearly four years ago when she kept feeling dry, poking sensations in her right eye. She chalked it up to a potential rip in her contact lens, the ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted priority review to veligrotug for the treatment of thyroid eye disease, according to a press ...

In 2016, researchers found that temporarily numbing both retinas could reverse vision loss from amblyopia, while a follow-up study in 2021 showed that numbing only the non-amblyopic eye could also ...

A recent MIT study is offering a new approach to treating one of the most common eye disorders: lazy eye. Scientifically known as amblyopia, the disorder often occurs when an eye and the brain stop ...

LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat ...

SHREVEPORT, La. - If you've ever noticed tiny spots, threads, or cobweb-like shapes drifting across your vision, you're not alone. They're called eye floaters, and in most cases, they're harmless.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Columbus biotech has landed ...

Warning: Luxury beauty is almost never on sale for this much and it WILL sell out quickly during QVC’s Nonstop Holiday Party. If your skin looks tired, let Peter Thomas Roth’s Retinol Fusion PM duo ...